Innoviva, Inc. - 10-Q Filing

Innoviva, Inc. reports Q3 2025 financial results featuring significant investment activity in Armata Pharmaceuticals and InCarda.

SEC EDGAR ·

Tickers: $INVA

Read the full article at SEC EDGAR

More Regulatory news